Management of urinary tract infections: Historical perspective and current strategies: Part 2 - Modern management

Journal of Urology

Volumn 173, Issue 1, 2005, Pages 27-32

  Nickel, J Curtis ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Anti bacterial agents; History of medicine; Urinary tract; Urinary tract infections

Indexed keywords

AMINOPENICILLIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFALEXIN; CEFALOTIN; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; ENOXACIN; GATIFLOXACIN; IMIPENEM; LEVOFLOXACIN; LOMEFLOXACIN; MERBROMIN; METHENAMINE; NALIDIXIC ACID; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFANILAMIDE;

AGRANULOCYTOSIS; COMPUTER ASSISTED TOMOGRAPHY; CYANOSIS; DATA BASE; DIAGNOSTIC TEST; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; HISTORY OF MEDICINE; HUMAN; IMAGING SYSTEM; INFORMATION PROCESSING; LABORATORY TEST; LITHOTRIPSY; LUNG FIBROSIS; MEDICAL INFORMATION; MEDLINE; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS DRAINAGE; PRIORITY JOURNAL; REVIEW; TREATMENT WITHDRAWAL; ULTRASOUND; URINALYSIS; URINARY TRACT INFECTION; X RAY ANALYSIS;

EID: 10344229480     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000141497.46841.7a     Document Type: Review

References (30)

1. Nickel, J. C.: Management of urinary tract infections: historical perspective and current strategies part 1 - before antibiotics. J Urol, 172: 000, 2005
2. Hyman, A. and Mann, L. T.: The nitrite reaction as an indicator of urinary infection. J Urol, 22: 521, 1929
3. Kaplan, D. M., Rosenfield, A. T. and Smith, R. C.: Advances in the imaging of renal infection. Helical CT and modern coordinated imaging. Infect Dis Clin North Am, 11: 681, 1997
4. Paradisi, F., Corti, G. and Mangani, V.: Urosepsis in the critical care unit. Crit Care Clin, 14: 165, 1998
5. Tunn, U. W. and Thieme, H.: Sepsis associated with urinary tract infection. Antibiotic treatment with piperacillin. Arch Intern Med, 142: 2035, 1982
6. Colemen, B. G., Arger, P. H., Mulhern, C. B., Jr., Pollack, H. M. and Banner, M. P.: Pyonephrosis: sonography in the diagnosis and management. AJR Am J Roentgenol, 137: 939, 1981
7. Shohl, A. T. and Deming, C. L.: Hexamethylenamin: its quantitative factors in therapy. J Urol, 4: 419, 1920
8. Young, H. H., White, E. C. and Swartz, E. O.: Further clinical studies on the use of mercurochrome - as a general germicide. J Urol, 5: 353, 1921
9. Mulholland, S. W.: The sulfonamides and penicillin as of today. J Urol, 57: 196, 1947
10. Crenshaw, J. L. and Cook, E. N.: Limitations, dangers, and failures of sulfanilamide in the treatment of urinary tract infections. J Urol, 41: 64, 1939
11. Mandell, G. L., Bennett, J. E. and Dolin, R.: Principles and Practices of Infectious Disease, 4th ed. Philadelphia: Churchill Livingstone, 1995
12. Nicolle, L. E.: Urinary tract infection: traditional pharmacologic therapies. Am J Med, suppl., 113: 35S, 2002
13. Karlowsky, J. A., Kelly, L. J., Thornsberry, C., Jones, M. E., Evangelista, A. T., Critchley, I. A. et al: Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance Network. Int J Antimicrob Agents, 19: 21, 2002
14. Roberts, W. O.: Urinary tract infections and the cost of antimicrobial resistance. A special report. Postgrad Med, suppl., 110: 1, 2001
15. Raz, R., Chazan, B., Kennes, Y., Colodner, R., Rottensterich, E., Dan, M. et al: Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Clin Infect Dis, 34: 1165, 2002
16. Gordon, K. A., Jones, R. N. and SENTRY Participant Groups (Europe, Latin America, North America): Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program (2000). Diagn Microbiol Infect Dis, 45: 295, 2003
17. Talan, D. A., Stamm, W. E., Hooton, T. M., Moran, G. J., Burke, T., Iravani, A. et al: Comparison of ciprofloxacin (7 days) and trimethoprim- sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial. JAMA, 283: 1583, 2000
18. Masterton, R. G. and Bochsler, J. A.: High-dosage co-amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women. J Antimicrob Chemother, 35: 129, 1995
19. McCarty, J. M., Richard, G., Huck, W., Tucker, R. M., Tosiello, R. L., Shan, M. et al: A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group. Am J Med, 106: 292, 1999
20. Hooper, D. C.: Mechanisms of action of antimicrobials: focus on fluoroquinolones. Clin Infect Dis, suppl., 32: S9, 2001
21. Karlowsky, J. A., Thornsberry, C., Jones, M. E. and Sahm, D. F.: Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin. Clin Infect Dis, 36: 183, 2003
22. Gupta, K., Hooton, T. M., Wobbe, C. L. and Stamm, W. E.: The prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in young women. Int J Antimicrob Agents, 11: 305, 1999
23. Gupta, K., Hooton, T. M. and Stamm, W. E.: Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med, 135: 41, 2001
24. Gupta, K., Sahm, D. F., Mayfield, D. and Stamm, W. E.: Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis, 33: 89, 2001
25. Warren, J. W., Abrutyn, E., Hebel, J. R., Johnson, J. R., Schaeffer, A. J. and Stamm, W. E.: Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis, 29: 745, 1999
26. Naber, K. G., Bergman, B., Bishop, M. C., Bjerklund-Johansen, T. E., Botto, H., Lobel, B. et al: EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Eur Urol, 40: 576, 2001
27. Wright, S. W., Wrenn, K. D. and Haynes, M. L.: Trimethoprim- sulfamethoxazole resistance among urinary coliform isolates. J Gen Intern Med, 14: 606, 1999
28. Gupta, K. and Stamm, W. E.: Outcomes associated with trimethoprim/ sulphamethoxazole (TMP/SMX) therapy in TMP/ SMX resistant community-acquired UTI. Int J Antimicrob Agents, 19: 554, 2002
29. Kahlmeter, G.: An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother, 51: 69, 2003
30. The Surveillance Network-Canada: Canadian National antimicrobial susceptibility patterns of E. coli isolated from UTI sources in 2001-2002: TSN-Canada database, 2003